Moloney Securities Asset Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-12,444
Closed -$344K – 316
2020
Q1
$344K Sell
12,444
-233
-2% -$6.98K 0.12% 168
2019
Q4
$371K Sell
12,677
-1,412
-10% -$33.6K 0.11% 215
2019
Q3
$269K Buy
+14,089
New +$330K 0.09% 252

Other funds holding NEO

Moloney Securities Asset Management's NEO Position: Q2 2020 in Review

Moloney Securities Asset Management sold out of NeoGenomics (NEO) in Q2 2020, closing a stake of 12,444 shares — an estimated $344K sold.

Moloney Securities Asset Management first reported a position in NEO in Q3 2019 and held it in 3 quarters. The position peaked at $371K in Q4 2019. 285 funds tracked by Wall St. Rank hold NEO as of Q2 2020.

  • Moloney Securities Asset Management reported no remaining NeoGenomics position as of Q2 2020 after selling out during the quarter.
  • Moloney Securities Asset Management sold 12,444 NeoGenomics shares in Q2 2020, an estimated $344K.
  • Moloney Securities Asset Management first reported a position in NeoGenomics in Q3 2019 and held it in 3 quarters.
  • Moloney Securities Asset Management's NeoGenomics position peaked at $371K in Q4 2019.
  • 285 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2020.

Based on Moloney Securities Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.